A detailed history of Eagle Asset Management Inc transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Eagle Asset Management Inc holds 153,532 shares of WST stock, worth $51.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
153,532
Previous 327,473 53.12%
Holding current value
$51.1 Million
Previous $108 Million 57.28%
% of portfolio
0.28%
Previous 0.6%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$277.16 - $333.3 $48.2 Million - $58 Million
-173,941 Reduced 53.12%
153,532 $46.1 Million
Q2 2024

Aug 12, 2024

SELL
$314.68 - $395.94 $5.16 Million - $6.49 Million
-16,397 Reduced 4.77%
327,473 $108 Million
Q1 2024

May 09, 2024

SELL
$338.27 - $413.0 $2.32 Million - $2.84 Million
-6,866 Reduced 1.96%
343,870 $136 Million
Q4 2023

Feb 12, 2024

BUY
$318.29 - $392.21 $40,422 - $49,810
127 Added 0.04%
350,736 $124 Million
Q3 2023

Nov 13, 2023

SELL
$354.9 - $412.41 $121,020 - $140,631
-341 Reduced 0.1%
350,609 $132 Million
Q2 2023

Aug 09, 2023

BUY
$334.63 - $382.47 $12.4 Million - $14.1 Million
36,969 Added 11.77%
350,950 $134 Million
Q1 2023

May 08, 2023

BUY
$232.5 - $346.47 $21.7 Million - $32.3 Million
93,172 Added 42.2%
313,981 $109 Million
Q4 2022

Feb 14, 2023

SELL
$209.34 - $261.61 $5.61 Million - $7.01 Million
-26,786 Reduced 10.82%
220,809 $52 Million
Q3 2022

Nov 07, 2022

BUY
$246.08 - $343.65 $225,409 - $314,783
916 Added 0.37%
247,595 $60.9 Million
Q2 2022

Aug 10, 2022

SELL
$280.61 - $420.45 $19.5 Million - $29.1 Million
-69,316 Reduced 21.94%
246,679 $74.6 Million
Q1 2022

May 12, 2022

BUY
$357.49 - $445.92 $1.53 Million - $1.9 Million
4,271 Added 1.37%
315,995 $130 Million
Q4 2021

Feb 11, 2022

BUY
$402.25 - $471.34 $709,569 - $831,443
1,764 Added 0.57%
311,724 $147 Million
Q3 2021

Nov 10, 2021

BUY
$363.01 - $468.47 $19.3 Million - $24.9 Million
53,164 Added 20.7%
309,960 $132 Million
Q2 2021

Aug 11, 2021

SELL
$284.77 - $363.2 $52,397 - $66,828
-184 Reduced 0.07%
256,796 $92.2 Million
Q1 2021

May 14, 2021

BUY
$257.29 - $307.53 $3.64 Million - $4.35 Million
14,137 Added 5.82%
256,980 $73.2 Million
Q4 2020

Feb 12, 2021

SELL
$261.16 - $301.66 $6.59 Million - $7.62 Million
-25,245 Reduced 9.42%
242,843 $68.8 Million
Q3 2020

Nov 12, 2020

SELL
$224.99 - $288.02 $765,415 - $979,844
-3,402 Reduced 1.25%
268,088 $73.4 Million
Q2 2020

Aug 12, 2020

BUY
$149.8 - $227.17 $32.5 Million - $49.3 Million
217,108 Added 399.23%
271,490 $59.8 Million
Q1 2020

May 11, 2020

BUY
$128.96 - $174.76 $3.55 Million - $4.81 Million
27,547 Added 102.65%
54,382 $8.23 Million
Q4 2019

Feb 07, 2020

SELL
$137.6 - $151.21 $3.27 Million - $3.59 Million
-23,773 Reduced 46.97%
26,835 $4.03 Million
Q3 2019

Nov 04, 2019

SELL
$121.41 - $150.02 $35 Million - $43.2 Million
-288,051 Reduced 85.06%
50,608 $7.18 Million
Q2 2019

Aug 05, 2019

SELL
$111.27 - $125.15 $3.75 Million - $4.22 Million
-33,684 Reduced 9.05%
338,659 $42.4 Million
Q1 2019

May 01, 2019

SELL
$94.53 - $110.2 $337,566 - $393,524
-3,571 Reduced 0.95%
372,343 $41 Million
Q4 2018

Feb 11, 2019

SELL
$93.0 - $123.98 $504,711 - $672,839
-5,427 Reduced 1.42%
375,914 $36.9 Million
Q3 2018

Nov 08, 2018

SELL
$98.01 - $123.47 $12.4 Million - $15.6 Million
-126,104 Reduced 24.85%
381,341 $47.1 Million
Q2 2018

Aug 07, 2018

SELL
$83.32 - $101.88 $8.58 Million - $10.5 Million
-102,955 Reduced 16.87%
507,445 $50.4 Million
Q1 2018

May 09, 2018

SELL
$85.56 - $102.4 $8.49 Million - $10.2 Million
-99,245 Reduced 13.99%
610,400 $53.9 Million
Q4 2017

Feb 09, 2018

SELL
$91.65 - $101.65 $16.7 Million - $18.5 Million
-181,920 Reduced 20.4%
709,645 $69.8 Million
Q3 2017

Nov 09, 2017

BUY
$84.54 - $96.75 $75.4 Million - $86.3 Million
891,565
891,565 $86.1 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.6B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.